Action

VEGFR2; KIT; Src

Alt Name

Approval Jurisdiction

2014 China 2018FDA

Approved for clinical use

Gastric cancer, NSCLC

Brutto

CAS

811803-05-1

Commercial Vendor

Elevar

Compound Image

Apatinib_Rivoceranib.png

Compound name

Apatinib

InChI

InChI=1S/C24H23N5O/c25-17-24(11-1-2-12-24)19-5-7-20(8-6-19)29-23(30)21-4-3-13-27-22(21)28-16-18-9-14-26-15-10-18/h3-10,13-15H,1-2,11-12,16H2,(H,27,28)(H,29,30)

InChI Key

WPEWQEMJFLWMLV-UHFFFAOYSA-N

MW

397.50

PubChem CID

11315474

Reference

Reference 2

SMILES

C1CCC(C1)(C#N)C2=CC=C(C=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4

Approved Drug List

1